| Application no. and date | 07820235.5 (espacenet) (Federated) (European Patent Register), 20070914 | | Patent/reg. no. and date | DK/EP 2068880, 20120411 | | Publication date | 20090617 | | Priority no. and date | EP 06120856, 20060918, EP 07101505, 20070131 | | EP pub. no. and date |
EP 2068880 20090617 | | Effective date | | | Applicant/owner | Boehringer Ingelheim International GmbH, Binger Straße 173
55216 Ingelheim am Rhein, DE | | Applicant ref. no. | 156707 | | Inventor | SOLCA, Flavio, Gesslgasse 10/6
1230 Vienna, AT | | Representative | AWA Denmark A/S, Strandgade 56, 1401 København K, DK | | Opponent | | | IPC Class | A61K 31/517 (2006.01) , A61P 35/00 (2006.01) | | Title | Fremgangsmåde til behandling af cancer, der huser EGFR-mutationer | | Int. application no. | EP2007059735 | | Int. publication no. | WO2008034776 | | Related patent (certificate) | | | Status | Ophævet | | Pædiatrisk forlængelse | - | | Udløbsdato for pædiatrisk forlængelse | - |
|
